Connect with us
MARE BALTICUM Gaming & TECH Summit 2024

Artificial Intelligence

Arrhythmia Monitoring Devices Market size worth $ 9.0 Billion, Globally, by 2028 at 6.12% CAGR: Verified Market Research®

Published

on

 

Verified Market Research recently published a report, “Arrhythmia Monitoring Devices Market” By Type (ECG Monitors, Implantable Monitors), By Application (Tachycardia, Bradycardia, Atrial Fibrillation), By End User (Hospitals and Diagnostic Centers, Ambulatory Centers), and By Geography. According to Verified Market Research, the Global Arrhythmia Monitoring Devices Market size was valued at USD 5.6 Billion in 2020 and is projected to reach USD 9.0 Billion by 2028, growing at a CAGR of 6.12% from 2021 to 2028.

Download PDF Brochure: https://www.verifiedmarketresearch.com/download-sample/?rid=31262

Browse in-depth TOC on “Arrhythmia Monitoring Devices Market

202 – Pages

126 – Tables

37 – Figures

Global Arrhythmia Monitoring Devices Market Overview

Rising incidence of cardiovascular diseases, favorable government policies, and rising adoption of low-cost ECG services among the lower-income group are the factors booming the growth of the global Arrhythmia Monitoring Devices Market. Although, the increasing focus on technological advancements and innovations is poised to blow the growth of the market. Also, an increase in product recalls of arrhythmia monitoring devices and complications related to these devices might impact negatively on the growth of the market. Patient-activated devices will only record what the patient recognizes to be symptomatic events.

Patients may also have difficulty activating the recorder while symptoms are being experienced, which may lead to the event being partially recorded. These limitations will not apply to automatic event-activated recorders as they can record both symptomatic and asymptomatic arrhythmias. In addition, depending on the programming used, the device may activate dispensable may not record during some symptomatic events. New Modern Technological advancements allowing remote monitoring of cardiac rhythm in patients will be the major Arrhythmia Monitoring Devices Market growth driving factor.

Key Developments

  • In January 2020, Biotronik announced the launch of a new injectable cardiac monitor, BIOMONITOR III, allowing detection of irregular heart rhythm. Such new product launches with technological development will increase the growth potential of the company.
  • In May 2019, Abbott announced the launch of next-generation heart monitor for cardiac arrhythmia detection in U.S. and Europe. This launch has offered business expansion opportunities to the firm in emerging economies.

Key Players

The major players in the market are BIOTRONIK, iRhythm, Medi-Lynx, Medtronic, Fukuda Denshi Co., Ltd. St. Jude Medical (Abbott), AliveCor, Inc., GE Healthcare, Applied Cardiac Systems, BioTelemetry, Inc., among others.

Verified Market Research has segmented the Global Arrhythmia Monitoring Devices Market On the basis of Type, Application, End User, and Geography.

  • Arrhythmia Monitoring Devices Market, By Type
    • ECG Monitors
    • Implantable Monitors
    • Holter Monitors
    • Mobile Cardiac Telemetry
  • Arrhythmia Monitoring Devices Market, By Application
    • Tachycardia
    • Bradycardia
    • Atrial Fibrillation
    • Premature Contraction
    • Others
  • Arrhythmia Monitoring Devices Market, By End Use
    • Hospitals and Diagnostic Centers
    • Ambulatory Centers
    • Others
  • Arrhythmia Monitoring Devices Market By Geography
    • North America
      • U.S
      • Canada
      • Mexico
    • Europe
      • Germany
      • France
      • U.K
      • Rest of Europe
    • Asia Pacific
      • China
      • Japan
      • India
      • Rest of Asia Pacific
    • ROW
      • Middle East & Africa
      • Latin America

Browse Related Reports:

Implantable Cardiac Monitor Market By Indication Type (Cardiac Arrhythmias, Atrial Fibrillation, Epilepsy & Unexplained falls), By End User (Hospitals, Ambulatory Surgical Centers, and Cardiac Center & Clinics), By Geography, Forecast, 2021-2028

ECG Holter Monitoring System Market by Lead Type (Patch Type 1 Lead Holter Monitor), by Component (Wired Holter Monitor, Wireless Holter, Holter Analysis System & Software), by End User (Hospitals and Clinic, Home Setting & Ambulatory Surgical Center), By Geography, Forecast, 2021-2028

Cardiac Output Monitoring Devices Market By Type (ECG Devices, Implantable Loop Recorders, Mobile Cardiac Telemetry Devices), By Technology (Lithium Dilution Technique, Arterial Waveform Analysis Technique, Doppler), By End User (Hospitals, Clinics, Cardiac Centers and Ambulatory Surgery Centers), By Geography, Forecast, 2021-2028

Cardiac Monitoring And Cardiac Rhythm Management Devices Market By Type (ECG Devices, Implantable Loop Recorders (ILR), Cardiac Output Monitoring Devices (COM)), By End-User (Hospitals, Clinics, and Cardiac Centers, Ambulatory Surgical Centers), By Geography, Forecast, 2021-2028

Top 9 Cardiac Pacemaker Devices Pumping the healthcare industry around the world

Visualize Arrhythmia Monitoring Devices Market using Verified Market Intelligence:-:

Verified Market Intelligence is our BI Enabled Platform for narrative storytelling of this market. VMI offers in-depth forecasted trends and accurate Insights on over 20,000+ emerging & niche markets, helping you make critical revenue impacting decisions for a brilliant future.

VMI provides a holistic overview and global competitive landscape with respect to Region, Country, and Segment, and Key players of your market. Present your Market Report & findings with an inbuilt presentation feature saving over 70% of your time and resources for Investor, Sales & Marketing, R&D, and Product Development pitches. VMI enables data delivery In Excel and Interactive PDF formats with over 15+ Key Market Indicators for your market.

Artificial Intelligence

PractiTest Pushes Boundaries of Test Management with Milestones Release

Published

on

practitest-pushes-boundaries-of-test-management-with-milestones-release

REHOVOT, Israel, May 6, 2024 /PRNewswire/ — PractiTest, a leader in innovative test management solutions, continues to push the boundaries with the release of Milestones, a powerful project management module enabling QA teams to align and stay connected to business goals. PractiTest’s New Milestones Module empowers QA teams to define high-level testing objectives within set timeframes. This results in well-defined roadmaps for sprint planning, major releases, or other pivotal project Milestones. By setting these objectives, QA teams gain a focused understanding of their contribution to broader business objectives and deadlines.

“Milestones have given us increased granularity in our ability to organize our testing,” says Tony, a system engineer at Battelle. “Having traceability was good, but Milestones allow us to plan much more clearly and easily.”
Milestones establish a seamless link between QA initiatives and overarching business strategies, ensuring testing efforts directly contribute to achieving company objectives. By defining clear testing objectives and schedules for each project phase, QA teams can stay on track and ensure efficient use of resources. The Milestones module also improves visibility, providing a high-level overview of the entire testing process and promoting seamless communication and collaboration among cross-functional teams.
PractiTest’s Commitment to Innovation
The release of Milestones reaffirms PractiTest’s dedication to providing cutting-edge solutions that empower QA teams to thrive.
“In today’s competitive environment, ensuring QA aligns with business objectives is imperative,” says Yaniv Iny, CEO of PractiTest. “The Milestones module is a testament to our commitment to empowering QA teams to evolve into strategic partners, fostering quality and delivering tangible outcomes while staying in sync with overarching business objectives.”
About PractiTest
PractiTest is an end-to-end test management platform designed to simplify and untangle complexity for complex and robust environments. PractiTest centralizes all your QA work, processes, teams, and tools into one platform to bridge silos, unify communication, and enable one source of truth across your organization. With PractiTest you can make informed data-driven decisions based on end-to-end visibility provided by customizable reports, real-time dashboards, and dynamic filter views.
For more information about PractiTest visit: https://www.practitest.com/
Media Contact:May [email protected]
Logo: https://mma.prnewswire.com/media/1997506/PractiTest_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/practitest-pushes-boundaries-of-test-management-with-milestones-release-302136603.html

Continue Reading

Artificial Intelligence

EZVIZ unveils its groundbreaking H9c Dual-lens Smart Pan-and-tilt Camera series: a new paradigm for automated, all-round outdoor protection

Published

on

ezviz-unveils-its-groundbreaking-h9c-dual-lens-smart-pan-and-tilt-camera-series:-a-new-paradigm-for-automated,-all-round-outdoor-protection

By combining a pan-and-tilt panoramic lens and a fixed 180-degree wide-angle lens, one H9c Dual smartly secures large areas with performance better than that of two ordinary ones.
HOOFDDORP, Netherlands, May 6, 2024 /PRNewswire/ — EZVIZ, a leading global player in innovative smart home security, proudly introduces the H9c Dual series, its latest dual-lens outdoor pan-and-tilt cameras that redefine smart protection for homes and small businesses. With options in 2K and 3K resolutions, their groundbreaking design combines a sharp bullet camera and a flexible PT camera, addressing complex security needs effectively. The interlinked dual lenses work collaboratively to safeguard wide property areas, detect and track activities, and offer auto-patrol options for hands-free security.

“The H9c Dual challenges traditional outdoor cameras with unrivaled vision, unmatched automation, and high versatility for basically any scenario,” said Candice Tu, the lead product manager, “EZVIZ leads the way in the development and application of advanced dual-lens technology. This underlines our dedication to bringing cutting-edge technology within reach for practical, everyday situations.”
At the core of the H9c Dual is its groundbreaking dual-lens technology, highlighted by EZVIZ’s distinctive co-action function. The two lenses can work independently at two static viewing angles or act together as a team. When the fixed lens detects motions, the pan-and-tilt lens automatically rotates to track the same activity. This co-action function can also be manually controlled through the EZVIZ App.
The series addresses unnoticed blind spots by offering a 180-degree comprehensive view in a single frame, supplemented by the bottom PT lens for intricate close-ups. Both lenses, with high resolutions of 2K/3K, use built-in AI chips to detect people and vehicles in customizable zones, ensuring users are informed of crucial activities. Users can set up to four patrol spots for the PT lens to complete automatic rotations on a schedule.
Equipped with powerful LEDs, the H9c Dual provides color night vision up to 40 meters and warns potential trespassers with a loud siren and dazzling flashlight upon detection. Offering superior protection compared to a traditional two-camera system, the H9c is a breeze to set up thanks to its adaptable mounting design. Users can manage and control their H9c through the user-friendly EZVIZ App, and enjoy seamless integration with prevailing voice assistants and the larger EZVIZ ecosystem.
Learn more at www.ezviz.com.
Photo – https://mma.prnewswire.com/media/2404810/EZVIZ_H9c_Dual_Lens_Pan_Tilt_Wi_Fi_Camera.jpg

View original content:https://www.prnewswire.co.uk/news-releases/ezviz-unveils-its-groundbreaking-h9c-dual-lens-smart-pan-and-tilt-camera-series-a-new-paradigm-for-automated-all-round-outdoor-protection-302136133.html

Continue Reading

Artificial Intelligence

Red light therapy for repairing spinal cord injury passes milestone

Published

on

red-light-therapy-for-repairing-spinal-cord-injury-passes-milestone

BIRMINGHAM, England, May 6, 2024 /PRNewswire/ — Patients with spinal cord injury (SCI) could benefit from future treatment to repair nerve connections using red and near-infrared light.

The method, invented by University of Birmingham scientists and patented by University of Birmingham Enterprise, delivers light directly to the site of the injury. 
Their latest research, published in Bioengineering and Translational Medicine, determined an optimal ‘dose’ for this novel approach, and showed it can deliver therapeutic improvements including significant restoration of sensation and movement, and regeneration of damaged nerve cells. 
Researchers led by Professor Zubair Ahmed used cell models of SCI to determine the frequency and duration of light required to achieve maximum restoration of function and stimulate nerve cell regrowth. 
They found delivery at a wavelength of 660nm for one minute a day increased cell viability (the number of live cells) by 45% over five days’ treatment. 
Professor Ahmed said: “The effect of 660nm light was both neuroprotective, meaning it improved survival of nerve cells, and neuroregenerative, meaning it stimulated nerve cell growth.” 
The researchers also investigated the effect of light therapy in preclinical models of SCI, using an implantable device and transcutaneous delivery with the light source placed against the skin. They showed comparable results for both methods, with a one-minute dose of 660nm light, delivered daily for seven days resulting in reduced tissue scarring, increased levels of proteins associated with nerve cell regeneration, improvements in the connections between cells and significant functional recovery. 
This is the first time transcutaneous and direct light delivery have been compared in SCI. Professor Ahmed said: “To make light therapy viable for treating SCI in humans an implantable device will be required, to provide line of sight to damaged tissue and the opportunity for greater accuracy and standardise dosing without impedance due to the thickness of the skin and other tissues surrounding the spinal cord.”
The researchers are planning to develop an implantable device for use in humans with traumatic SCI. They have already received further funding and are seeking commercial partners or investors to develop a prototype device to take into first-in-man clinical trials.
Full release here. 
University of Birmingham Enterprise helps researchers turn ideas into products and services that meet real-world needs. Follow us on LinkedIn and X.
Photo: https://mma.prnewswire.com/media/2404909/University_of_Birmingham_Enterprise.jpg
Media enquiries: Ruth Ashton
Commercial enquiries: Veemal Bhowruth

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/red-light-therapy-for-repairing-spinal-cord-injury-passes-milestone-302136233.html

Continue Reading

Trending